First Generic of Symbicort Receives FDA Approval

The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in patients with chronic obstructive pulmonary disease (COPD).

Next post in Acne